ONHS Report: HT942526VRPCTA

DoW Vision, Clinical Trial Award

Solicitation ID: HT942526VRPCTA

Agency: DHA

Type: Grant

Deadline: 2026-11-12T00:00:00 ET

Eligibility: Yes (Unrestricted)

Funding: Approximately $2.6M to fund one award, with a total cost cap of $2.6M for a 3-year period of performance.

Doc Type: BAA

Clearance: No

Program Manager: help@eBRAP.org

Last Updated: 2026-08-19 14:59

Analyzed File: HT942526VRPCTA_GG.pdf

Eligibility Reasoning

Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. ... Applications from investigators within the DOW and applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA), funding opportunity HT942526VRPCTA, supports the rapid implementation of clinical trials with the potential to significantly impact the treatment or management of service-connected eye injury and visual dysfunction. Proposed research must align with at least one of the specified FY26 VRP Focus Areas. The award is intended for a range of clinical trials, from small proof-of-concept to large-scale efficacy studies. A critical requirement is that for interventions needing an Investigational New Drug (IND) or Investigational Device Exemption (IDE), the application must be submitted to the regulatory agency by the CTA application deadline, and documentation indicating the application is 'active/safe to proceed' must be provided by March 1, 2027. The program expects to fund approximately one award with a total cost cap of $2.6 million over a maximum period of three years.

Overall Technical Areas

Clinical Trial DesignOcular Injury TreatmentVisual Dysfunction ResearchTraumatic Brain Injury (TBI) ResearchAustere Environment Medical CareProlonged Field Care TechnologiesVisual Function RestorationPharmacologic Agent DevelopmentInvestigational Medical DevicesSurgical InterventionsBiostatistics and Data AnalysisRegulatory Science (IND/IDE)Human Subjects ResearchPreclinical PharmacologyBiospecimen Science

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Understand and treat eye injury or visual dysfunction as related to military exposure
Diagnose, stabilize and treat eye injuries in austere environments and prolonged care settings
Restore visual function after military exposure-related vision loss or severe visual impairment

Specific Technical Skills:

Understand and treat eye injury or visual dysfunction as related to military exposureDiagnose, stabilize and treat eye injuries in austere environments and prolonged care settingsRestore visual function after military exposure-related vision loss or severe visual impairment

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Karthik Shekhar	0.72	BSA \| Biological Systems & Engineering \| Biodesign Dept · Visual Dysfunction Research
Zixi Hu	0.72	CSA \| AMCR \| Mathematics · Biostatistics and Data Analysis
Kevin Fan	0.71	LD \| LD \| Strategic Partnerships · Traumatic Brain Injury (TBI) Research
Gerard Marriott	0.71	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Pharmacologic Agent Development
Michelle O'Malley	0.70	BSA \| Biological Systems & Engineering \| Biodesign Dept · Biospecimen Science
Aris Polyzos	0.70	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Preclinical Pharmacology
Drew Paine	0.70	CSA \| SciData \| Data Science Applications · Human Subjects Research
Jamie Inman	0.70	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Investigational Medical Devices
Eleanor Zizka	0.69	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Clinical Trial Design
Amy Kronenberg	0.69	BSA \| Biological Systems & Engineering \| Biodesign Dept · Austere Environment Medical Care

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.